(Q27486108)

English

Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects

scientific article (publication date: May 2008)

Statements

Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects (English)
0 references
0 references
0 references
0 references
0 references
0 references
Michael L Remington
0 references
Florentina Teofilovici
0 references
May 2008
0 references
15
0 references
5
0 references
773-82
0 references

Identifiers

0 references
0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit